The impact of diabetes on the pathogenesis of sepsis

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 31, Issue 4, 2012, Pages 379-388

  Koh, G C K W ^a,b,c,d   Peacock, S J ^d   Van Der Poll, T ^b   Wiersinga, W J ^b  

^a WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

^c BIRMINGHAM HEARTLANDS HOSPITAL   (United Kingdom)

^d UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHROMBIN; BLOOD CLOTTING FACTOR 9; C REACTIVE PROTEIN; CIGLITAZONE; GLIBENCLAMIDE; GLITAZONE DERIVATIVE; GLUCOSE; INSULIN; INTERLEUKIN 10; INTERLEUKIN 6; INTERLEUKIN 8; METFORMIN; ROSIGLITAZONE; SULFONYLUREA DERIVATIVE; THROMBIN ANTITHROMBIN COMPLEX; TUMOR NECROSIS FACTOR ALPHA;

COMORBIDITY; COMPLEMENT DEFICIENCY; DIABETES MELLITUS; DIABETIC DIET; DISEASE ASSOCIATION; DRUG MECHANISM; GLUCOSE BLOOD LEVEL; HUMAN; HUMORAL IMMUNE DEFICIENCY; HYPERGLYCEMIA; IMMUNE RESPONSE; IMMUNOMODULATION; INFECTION RISK; INFECTION SENSITIVITY; INFLAMMATION; INTRACELLULAR KILLING; KIDNEY INJURY; LEUKOCYTE ADHERENCE; LYMPHOCYTE FUNCTION; MONOCYTE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PATHOGENESIS; PHAGOCYTOSIS; PRIORITY JOURNAL; REVIEW; SEPSIS; STREPTOCOCCUS PNEUMONIA;

DIABETES COMPLICATIONS; DIABETES MELLITUS; DISEASE SUSCEPTIBILITY; HUMANS; HYPOGLYCEMIC AGENTS; IMMUNITY, HUMORAL; NEUTROPHILS; SEPSIS;

EID: 84862859101     PISSN: 09349723     EISSN: 14354373     Source Type: Journal    
DOI: 10.1007/s10096-011-1337-4     Document Type: Review

References (150)

1. Muller LMAJ, Gorter KJ, Hak E, Goudzwaard WL, Schellevis FG, Hoepelman AIM, Rutten GEHM (2005) Increased risk of common infections in patients with type 1 and type 2 diabetes mellitus. Clin Infect Dis 41:281-288 (Pubitemid 41022101)
2. Shah BR, Hux JE (2003) Quantifying the risk of infectious diseases for people with diabetes. Diabetes Care 26:510-513 (Pubitemid 36929083)
3. Finfer S, Chittock DR, Su SY-S, Blair D, Foster D, Dhingra V, Bellomo R, Cook D, Dodek P, Henderson WR, Hébert PC, Heritier S, Heyland DK, McArthur C, McDonald E, Mitchell I, Myburgh JA, Norton R, Potter J, Robinson BG, Ronco JJ (2009) Intensive versus conventional glucose control in critically ill patients. N Engl J Med 360:1283-1297
4. Stegenga ME, Vincent J-L, Vail GM, Xie J, Haney DJ, Williams MD, Bernard GR, van der Poll T (2010) Diabetes does not alter mortality or hemostatic and inflammatory responses in patients with severe sepsis. Crit Care Med 38:539-545
5. Restrepo BI (2007) Convergence of the tuberculosis and diabetes epidemics: renewal of old acquaintances. Clin Infect Dis 45:436-438 (Pubitemid 47204458)
6. Joslin EP (1916) The treatment of diabetes mellitus: with observations upon the disease based upon one thousand cases. Lea & Febiger, Philadelphia
7. Bertoni AG, Saydah S, Brancati FL (2001) Diabetes and the risk of infection-related mortality in the U.S. Diabetes Care 24:1044-1049 (Pubitemid 33716374)
8. Chandler JR (1968) Malignant external otitis. Laryngoscope 78:1257-1294
9. Ali T, Meade K, Anari S, ElBadawey MR, Zammit-Maempel I (2010) Malignant otitis externa: case series. J Laryngol Otol 124:846-851
10. Carfrae MJ, Kesser BW (2008) Malignant otitis externa. Otolaryngol Clin North Am 41:537-549, viii-ix (Pubitemid 351635801)
11. Khaira A, Gupta A, Rana DS, Gupta A, Bhalla A, Khullar D (2009) Retrospective analysis of clinical profile prognostic factors and outcomes of 19 patients of emphysematous pyelonephritis. Int Urol Nephrol 41:959-966
12. Michaeli J, Mogle P, Perlberg S, Heiman S, Caine M (1984) Emphysematous pyelonephritis. J Urol 131:203-208 (Pubitemid 14179823)
13. Ahlering TE, Boyd SD, Hamilton CL, Bragin SD, Chandrasoma PT, Lieskovsky G, Skinner DG (1985) Emphysematous pyelonephritis: a 5-year experience with 13 patients. J Urol 134:1086-1088 (Pubitemid 16207001)
14. Cook DJ, Achong MR, Dobranowski J (1989) Emphysematous pyelonephritis. Complicated urinary tract infection in diabetes. Diabetes Care 12:229-232 (Pubitemid 19071494)
15. Esper AM, Moss M, Martin GS (2009) The effect of diabetes mellitus on organ dysfunction with sepsis: an epidemiological study. Crit Care 13:R18
16. Thomsen RW, Hundborg HH, Lervang H-H, Johnsen SP, Sørensen HT, Schønheyder HC (2004) Diabetes and outcome of community-acquired pneumococcal bacteremia: a 10-year population-based cohort study. Diabetes Care 27:70-76 (Pubitemid 38196712)
17. Tsai F-C, Huang Y-T, Chang L-Y, Wang J-T (2008) Pyogenic liver abscess as endemic disease, Taiwan. Emerg Infect Dis 14:1592-1600
18. Gregory JE, Golden A, Haymaker W (1943) Mucormycosis of the central nervous system: a report of three cases. Bull Johns Hopkins Hosp 73:405-419
19. Mallis A, Mastronikolis SN, Naxakis SS, Papadas AT (2010) Rhinocerebral mucormycosis: an update. Eur Rev Med Pharmacol Sci 14:987-992
20. Cheng AC, Currie BJ (2005) Melioidosis: epidemiology, pathophysiology, and management. Clin Microbiol Rev 18:383-416 (Pubitemid 40548298)
21. Dooley KE, Chaisson RE (2009) Tuberculosis and diabetes mellitus: convergence of two epidemics. Lancet Infect Dis 9:737-746
22. Fine MJ, Smith MA, Carson CA, Mutha SS, Sankey SS, Weissfeld LA, Kapoor WN (1996) Prognosis and outcomes of patients with community-acquired pneumonia. A meta-analysis. JAMA 275:134-141
23. Thomsen RW, Hundborg HH, Lervang H-H, Johnsen SP, Schønheyder HC, Sørensen HT (2005) Diabetes mellitus as a risk and prognostic factor for community-acquired bacteremia due to enterobacteria: a 10-year, population-based study among adults. Clin Infect Dis 40:628-631 (Pubitemid 40270239)
24. Kornum JB, Thomsen RW, Riis A, Lervang H-H, Schønheyder HC, Sørensen HT (2007) Type 2 diabetes and pneumonia outcomes: a population-based cohort study. Diabetes Care 30:2251-2257 (Pubitemid 47359027)
25. Falagas ME, Alexiou VG, Giannopoulou KP, Siempos II (2007) Risk factors for mortality in patients with emphysematous pyelonephritis: a meta-analysis. J Urol 178:880-885, quiz 1129 (Pubitemid 47211058)
26. Vincent J-L, Preiser J-C, Sprung CL, Moreno R, Sakr Y (2010) Insulin-treated diabetes is not associated with increased mortality in critically ill patients. Crit Care 14:R12
27. Michalia M, Kompoti M, Koutsikou A, Paridou A, Giannopoulou P, Trikka-Graphakos E, Clouva-Molyvdas P (2009) Diabetes mellitus is an independent risk factor for ICU-acquired bloodstream infections. Intensive Care Med 35:448-454
28. Tsai CL, Lee CC, Ma MH, Fang CC, Chen SY, Chen WJ, Chang SC, Mehta SH (2007) Impact of diabetes on mortality among patients with community-acquired bacteremia. J Infect 55:27-33 (Pubitemid 46900074)
29. McAlister FA, Majumdar SR, Blitz S, Rowe BH, Romney J, Marrie TJ (2005) The relation between hyperglycemia and outcomes in 2,471 patients admitted to the hospital with community-acquired pneumonia. Diabetes Care 28:810-815 (Pubitemid 40434478)
30. Kaplan V, Angus DC, Griffin MF, Clermont G, Scott Watson R, Linde-Zwirble WT (2002) Hospitalized community-acquired pneumonia in the elderly: age- and sex-related patterns of care and outcome in the United States. Am J Respir Crit Care Med 165:766-772 (Pubitemid 34229645)
31. Cooper G, Platt R (1982) Staphylococcus aureus bacteremia in diabetic patients. Endocarditis and mortality. Am J Med 73:658-662 (Pubitemid 13234220)
32. Libert M, Elkholti M, Massaut J, Karmali R, Mascart G, Cherifi S (2008) Risk factors for meticillin resistance and outcome of Staphylococcus aureus bloodstream infection in a Belgian university hospital. J Hosp Infect 68:17-24
33. Carton JA, Maradona JA, Nuño FJ, Fernandez-Alvarez R, Pérez-Gonzalez F, Asensi V (1992) Diabetes mellitus and bacteraemia: a comparative study between diabetic and non-diabetic patients. Eur J Med 1:281-287
34. Vardakas KZ, Siempos II, Falagas ME (2007) Diabetes mellitus as a risk factor for nosocomial pneumonia and associated mortality. Diabet Med 24:1168-1171 (Pubitemid 47437883)
35. Graham BB, Keniston A, Gajic O, Trillo Alvarez CA, Medvedev S, Douglas IS (2010) Diabetes mellitus does not adversely affect outcomes from a critical illness. Crit Care Med 38:16-24
36. Gong MN, Thompson BT, Williams P, Pothier L, Boyce PD, Christiani DC (2005) Clinical predictors of and mortality in acute respiratory distress syndrome: potential role of red cell transfusion. Crit Care Med 33:1191-1198 (Pubitemid 40827364)
37. Moss M, Guidot DM, Steinberg KP, Duhon GF, Treece P, Wolken R, Hudson LD, Parsons PE (2000) Diabetic patients have a decreased incidence of acute respiratory distress syndrome. Crit Care Med 28:2187-2192 (Pubitemid 30604414)
38. Koh GCKW, Maude RR, Schreiber MF, Limmathurotsakul D, Wiersinga WJ, Wuthiekanun V, Lee SJ, Mahavanakul W, Chaowagul W, Chierakul W, White NJ, van der Poll T, Day NP, Dougan G, Peacock SJ (2011) Glyburide is anti-inflammatory and associated with reduced mortality in melioidosis. Clin Infect Dis 52:717-725
39. Watson RS, Angus DC (2002) Assessing outcomes in critical care. J Intensive Care Med 17:103-111 (Pubitemid 44718448)
40. Schisterman EF, Cole SR, Platt RW (2009) Overadjustment bias and unnecessary adjustment in epidemiologic studies. Epidemiology 20:488-495
41. Hennekens CH, Buring JE (1987) Epidemiology in medicine. Lippincott Williams & Wilkins, Philadelphia, p 287
42. Lassar O (1904) Ernährungstherapie bei Hautkrankheiten. Dermatologische Zeitschrift 11:189-209
43. Handmann E (1911) Über die Ursache der verminderten Resistenz des Diabetikers gegen Infektionen. Deutsches Archiv Für Klinische Medizin 102:1-14
44. Da Costa JC Jr (1907) The opsonic index in diabetes mellitus: a preliminary record of the findings in 22 cases of glycosuria, with remarks on the technique of the opsonin test and on its clinical utility. Am J Med Sci 134:57-70
45. Balasoiu D, van Kessel KC, van Kats-Renaud HJ, Collet TJ, Hoepelman AI (1997) Granulocyte function in women with diabetes and asymptomatic bacteriuria. Diabetes Care 20:392-395 (Pubitemid 27098230)
46. Pickup JC, Mattock MB, Chusney GD, Burt D (1997) NIDDM as a disease of the innate immune system: association of acute-phase reactants and interleukin-6 with metabolic syndrome X. Diabetologia 40:1286-1292 (Pubitemid 27469668)
47. Myśliwska J, Zorena K, Bakowska A, Skuratowicz-Kubica A, Myśliwski A (1998) Significance of tumor necrosis factor alpha in patients with long-standing type-I diabetes mellitus. Horm Metab Res 30:158-161 (Pubitemid 28172525)
48. Zozuliñska D, Majchrzak A, Sobieska M, Wiktorowicz K, Wierusz-Wysocka B (1999) Serum interleukin-8 level is increased in diabetic patients. Diabetologia 42:117-118 (Pubitemid 29039749)
49. Yende S, van der Poll T, Lee M, Huang DT, Newman AB, Kong L, Kellum JA, Harris TB, Bauer D, Satterfield S, Angus DC (2010) The influence of pre-existing diabetes mellitus on the host immune response and outcome of pneumonia: analysis of two multicentre cohort studies. Thorax 65:870-877
50. Rao AK, Chouhan V, Chen X, Sun L, Boden G (1999) Activation of the tissue factor pathway of blood coagulation during prolonged hyperglycemia in young healthy men. Diabetes 48:1156-1161 (Pubitemid 29226365)
51. Stegenga ME, van der Crabben SN, Levi M, de Vos AF, Tanck MW, Sauerwein HP, van der Poll T (2006) Hyperglycemia stimulates coagulation, whereas hyperinsulinemia impairs fibrinolysis in healthy humans. Diabetes 55:1807-1812 (Pubitemid 44324136)
52. Geerlings SE, Brouwer EC, Van Kessel KC, Gaastra W, Stolk RP, Hoepelman AI (2000) Cytokine secretion is impaired in women with diabetes mellitus. Eur J Clin Invest 30:995-1001
53. Aird WC (2003) The role of the endothelium in severe sepsis and multiple organ dysfunction syndrome. Blood 101:3765-3777 (Pubitemid 36857845)
54. Schuetz P, Yano K, Sorasaki M, Ngo L, St Hilaire M, Lucas JM, Aird W, Shapiro NI (2011) Influence of diabetes on endothelial cell response during sepsis. Diabetologia 54:996-1003
55. Neelamegham S, Taylor AD, Burns AR, Smith CW, Simon SI (1998) Hydrodynamic shear shows distinct roles for LFA-1 and Mac-1 in neutrophil adhesion to intercellular adhesion molecule-1. Blood 92:1626-1638 (Pubitemid 28406866)
56. Hentzen ER, Neelamegham S, Kansas GS, Benanti JA, McIntire LV, Smith CW, Simon SI (2000) Sequential binding of CD11a/CD18 and CD11b/CD18 defines neutrophil capture and stable adhesion to intercellular adhesion molecule-1. Blood 95:911-920 (Pubitemid 30062713)
57. Li J, Jin H-B, Sun Y-M, Su Y, Wang L-F (2010) KB-R7943 inhibits high glucose-induced endothelial ICAM-1 expression and monocyte-endothelial adhesion. Biochem Biophys Res Commun 392:516-519
58. Takami S, Yamashita S, Kihara S, Kameda-Takemura K, Matsuzawa Y (1998) High concentration of glucose induces the expression of intercellular adhesion molecule-1 in human umbilical vein endothelial cells. Atherosclerosis 138:35-41 (Pubitemid 28255152)
59. Altannavch TS, Roubalová K, Kucera P, Andel M (2004) Effect of high glucose concentrations on expression of ELAM-1, VCAM-1 and ICAM-1 in HUVEC with and without cytokine activation. Physiol Res 53:77-82 (Pubitemid 38295544)
60. Andersen B, Goldsmith GH, Spagnuolo PJ (1988) Neutrophil adhesive dysfunction in diabetes mellitus; the role of cellular and plasma factors. J Lab Clin Med 111:275-285 (Pubitemid 18082751)
61. Delamaire M, Maugendre D, Moreno M, Le Goff MC, Allannic H, Genetet B (1997) Impaired leucocyte functions in diabetic patients. Diabet Med 14:29-34 (Pubitemid 27019919)
62. Morigi M, Angioletti S, Imberti B, Donadelli R, Micheletti G, Figliuzzi M, Remuzzi A, Zoja C, Remuzzi G (1998) Leukocyte-endothelial interaction is augmented by high glucose concentrations and hyperglycemia in a NF-κB-dependent fashion. J Clin Invest 101:1905-1915 (Pubitemid 28226110)
63. Taki H, Kashiwagi A, Tanaka Y, Horiike K (1996) Expression of intercellular adhesion molecules 1 (ICAM-1) via an osmotic effect in human umbilical vein endothelial cells exposed to high glucose medium. Life Sci 58:1713-1721 (Pubitemid 26147106)
64. Park CW, Kim JH, Lee JH, Kim YS, Ahn HJ, Shin YS, Kim SY, Choi EJ, Chang YS, Bang BK (2000) High glucose-induced intercellular adhesion molecule-1 (ICAM-1) expression through an osmotic effect in rat mesangial cells is PKC-NF-κB-dependent. Diabetologia 43:1544-1553 (Pubitemid 32734862)
65. Boyden S (1962) The chemotactic effect of mixtures of antibody and antigen on polymorphonuclear leucocytes. J Exp Med 115:453-466
66. Mowat A, Baum J (1971) Chemotaxis of polymorphonuclear leukocytes from patients with diabetes mellitus. N Engl J Med 284:621-627
67. Valerius NH, Eff C, Hansen NE, Karle H, Nerup J, Søeberg B, Sørensen SF (1982) Neutrophil and lymphocyte function in patients with diabetes mellitus. Acta Med Scand 211:463-467 (Pubitemid 12087654)
68. Nelson RD, Quie PG, Simmons RL (1975) Chemotaxis under agarose: a new and simple method for measuring chemotaxis and spontaneous migration of human polymorphonuclear leukocytes and monocytes. J Immunol 115:1650-1656
69. Tater D, Tepaut B, Bercovici JP, Youinou P (1987) Polymorphonuclear cell derangements in type I diabetes. Horm Metab Res 19:642-647 (Pubitemid 18014150)
70. Bybee JD, Rogers DE (1964) The phagocytic activity of polymorphonuclear leukocytes obtained from patients with diabetes mellitus. J Lab Clin Med 64:1-13
71. Bagdade JD, Root RK, Bulger RJ (1974) Impaired leukocyte function in patients with poorly controlled diabetes. Diabetes 23:9-15
72. Bagdade JD (1976) Phagocytic and microbicidal function in diabetes mellitus. Acta Endocrinol Suppl (Copenh) 205:27-34
73. Alexiewicz JM, Kumar D, Smogorzewski M, Klin M, Massry SG (1995) Polymorphonuclear leukocytes in non-insulin-dependent diabetes mellitus: abnormalities in metabolism and function. Ann Intern Med 123:919-924
74. Davidson NJ, Sowden JM, Fletcher J (1984) Defective phagocytosis in insulin controlled diabetics: evidence for a reaction between glucose and opsonising proteins. J Clin Pathol 37:783-786 (Pubitemid 14076750)
75. Dziatkowiak H, Kowalska M, Denys A (1982) Phagocytic and bactericidal activity of granulocytes in diabetic children. Diabetes 31:1041-1043 (Pubitemid 13242233)
76. Tan JS, Anderson JL, Watanakunakorn C, Phair JP (1975) Neutrophil dysfunction in diabetes mellitus. J Lab Clin Med 85 (1):26-33
77. Bagdade JD, Nielson KL, Bulger RJ (1972) Reversible abnormalities in phagocytic function in poorly controlled diabetic patients. Am J Med Sci 263:451-456
78. Wilson RM, Reeves WG (1986) Neutrophil phagocytosis and killing in insulin-dependent diabetes. Clin Exp Immunol 63:478-484 (Pubitemid 16155825)
79. Shah SV, Wallin JD, Eilen SD (1983) Chemiluminescence and superoxide anion production by leukocytes from diabetic patients. J Clin Endocrinol Metab 57:402-409 (Pubitemid 13032498)
80. Wykretowicz A, Wierusz-Wysocka B, Wysocki J, Szczepanik A, Wysocki H (1993) Impairment of the oxygen-dependent micro-bicidal mechanisms of polymorphonuclear neutrophils in patients with type 2 diabetes is not associated with increased susceptibility to infection. Diabetes Res Clin Pract 19:195-201 (Pubitemid 23176578)
81. Sato N, Kashima K, Tanaka Y, Shimizu H, Mori M (1997) Effect of granulocyte-colony stimulating factor on generation of oxygen-derived free radicals and myeloperoxidase activity in neutrophils from poorly controlled NIDDM patients. Diabetes 46:133-137 (Pubitemid 27009961)
82. Daoud AK, Tayyar MA, Fouda IM, Harfeil NA (2009) Effects of diabetes mellitus vs. in vitro hyperglycemia on select immune cell functions. J Immunotoxicol 6:36-41
83. Brinkmann V, Reichard U, Goosmann C, Fauler B, Uhlemann Y, Weiss DS, Weinrauch Y, Zychlinsky A (2004) Neutrophil extracellular traps kill bacteria. Science 303:1532-1535 (Pubitemid 38314426)
84. Grinberg N, Elazar S, Rosenshine I, Shpigel NY (2008) β-Hydroxybutyrate abrogates formation of bovine neutrophil extracellular traps and bactericidal activity against mammary pathogenic Escherichia coli. Infect Immun 76:2802-2807
85. Hill HR, Augustine NH, Rallison ML, Santos JI (1983) Defective monocyte chemotactic responses in diabetes mellitus. J Clin Immunol 3:70-77 (Pubitemid 13154041)
86. Geisler C, Almdal T, Bennedsen J, Rhodes JM, Kølendorf K (1982) Monocyte functions in diabetes mellitus. Acta Pathol Microbiol Immunol Scand C 90:33-37 (Pubitemid 12177110)
87. Katz S, Klein B, Elian I, Fishman P, Djaldetti M (1983) Phagocytotic activity of monocytes from diabetic patients. Diabetes Care 6:479-482 (Pubitemid 13005557)
88. Nandy D, Janardhanan R, Mukhopadhyay D, Basu A (2011) Effect of hyperglycemia on human monocyte activation. J Investig Med 59:661-667
89. Rattan V, Shen Y, Sultana C, Kumar D, Kalra VK (1996) Glucose-induced transmigration of monocytes is linked to phosphorylation of PECAM-1 in cultured endothelial cells. Am J Physiol 271:E711-E717
90. Kitahara M, Eyre HJ, Lynch RE, Rallison ML, Hill HR (1980) Metabolic activity of diabetic monocytes. Diabetes 29:251-256 (Pubitemid 10138618)
91. Foss-Freitas MC, Foss NT, Donadi EA, Foss MC (2006) In vitro TNF-alpha and IL-6 production by adherent peripheral blood mononuclear cells obtained from type 1 and type 2 diabetic patients evaluated according to the metabolic control. Ann N Y Acad Sci 1079:177-180 (Pubitemid 44968720)
92. MacCuish AC, Urbaniak SJ, Campbell CJ, Duncan LJ, Irvine WJ (1974) Phytohemagglutinin transformation and circulating lymphocyte subpopulations in insulin-dependent diabetic patients. Diabetes 23:708-712
93. Speert DP, Silva J Jr (1978) Abnormalities of in vitro lymphocyte response to mitogens in diabetic children during acute ketoacidosis. Am J Dis Child 132:1014-1017 (Pubitemid 9133166)
94. Eibl N, Spatz M, Fischer GF, Mayr WR, Samstag A, Wolf HM, Schernthaner G, Eibl MM (2002) Impaired primary immune response in type-1 diabetes: results from a controlled vaccination study. Clin Immunol 103:249-259 (Pubitemid 34666748)
95. Spatz M, Eibl N, Hink S, Wolf HM, Fischer GF, Mayr WR, Schernthaner G, Eibl MM (2003) Impaired primary immune response in type-1 diabetes. Functional impairment at the level of APCs and T-cells. Cell Immunol 221:15-26 (Pubitemid 36555390)
96. Casey J, Sturm C Jr (1982) Impaired response of lymphocytes from non-insulin-dependent diabetics to staphage lysate and tetanus antigen. J Clin Microbiol 15:109-114 (Pubitemid 12251222)
97. Casey JI, Heeter BJ, Klyshevich KA (1977) Impaired response of lymphocytes of diabetic subjects to antigen of Staphylococcus aureus. J Infect Dis 136:495-501 (Pubitemid 8211381)
98. Da Costa JC Jr, Beardsley EJG (1908) The resistance of diabetics to bacterial infection: a study of the opsonophagocytic properties of the blood in 74 cases of diabetes mellitus and related conditions. Am J Med Sci 136:361-373
99. Liberatore RDR Jr, Barbosa SFC, Das Graças Alkimin M, Bellinati-Pires R, Florido MPC, Isaac L, Kirschfink M, Grumach AS (2005) Is immunity in diabetic patients influencing the susceptibility to infections? Immunoglobulins, complement and phagocytic function in children and adolescents with type 1 diabetes mellitus. Pediatr Diabetes 6:206-212 (Pubitemid 43013628)
100. Moen JK, Reimann HA (1933) Immune reactions in diabetes. Arch Intern Med 51:789-795
101. Richardson R (1933) Immunity in diabetes: influence of diabetes on the development of antibacterial properties in the blood. J Clin Invest 12:1143-1149
102. Fiçicioǧlu C, Mikla S, Midilli K, Aydin A, Cam H, Erǧin S (1995) Reduced immune response to hepatitis B vaccine in children with insulin dependent diabetes. Acta Paediatr Jpn 37:687-690 (Pubitemid 26018730)
103. Pozzilli P, Arduini P, Visalli N, Sutherland J, Pezzella M, Galli C, Corradini SG, Biasio L, Gale EA, Andreani D (1987) Reduced protection against hepatitis B virus following vaccination in patients with type 1 (insulin-dependent) diabetes. Diabetologia 30:817-819 (Pubitemid 17163009)
104. Alavian S-M, Tabatabaei SV (2010) The effect of diabetes mellitus on immunological response to hepatitis B virus vaccine in individuals with chronic kidney disease: a meta-analysis of current literature. Vaccine 28:3773-3777
105. Bouter KP, Diepersloot RJ, Wismans PJ, Gmelig Meyling FH, Hoekstra JB, Heijtink RA, van Hattum J (1992) Humoral immune response to a yeast-derived hepatitis B vaccine in patients with type 1 diabetes mellitus. Diabet Med 9:66-69
106. Douvin C, Simon D, Charles MA, Deforges L, Bierling P, Lehner V, Budkowska A, Dhumeaux D (1997) Hepatitis B vaccination in diabetic patients. Randomized trial comparing recombinant vaccines containing and not containing pre-S2 antigen. Diabetes Care 20:148-151 (Pubitemid 27051551)
107. Brydak LB, Machala M (2000) Humoral immune response to influenza vaccination in patients from high risk groups. Drugs 60:35-53 (Pubitemid 30601315)
108. Pozzilli P, Gale EA, Visalli N, Baroni M, Crovari P, Frighi V, Cavallo MG, Andreani D (1986) The immune response to influenza vaccination in diabetic patients. Diabetologia 29:850-854 (Pubitemid 17000996)
109. Muszkat M, Friedman G, Dannenberg HD, Greenbaum E, Lipo M, Heymann Y, Zakay-Rones Z, Ben-Yehuda A (2003) Response to influenza vaccination in community and in nursing home residing elderly: relation to clinical factors. Exp Gerontol 38:1199-1203 (Pubitemid 37324431)
110. Tamer A, Karabay O, Ekerbicer H, Tahtaci M, Selam B, Celebi H (2005) Impaired immunity against tetanus in type 2 diabetes. Med Sci Monit 11:CR580-CR584 (Pubitemid 43138423)
111. Kiliç D, Kaygusuz S, Saygun M, Cakmak A, Uzer H, Doǧanci L (2003) Seroprevalence of tetanus immunity among noninsulin-dependent diabetes mellitus patients. J Diabetes Complications 17:258-263 (Pubitemid 37040772)
112. Beam TR Jr, Crigler ED, Goldman JK, Schiffman G (1980) Antibody response to polyvalent pneumococcal polysaccharide vaccine in diabetics. JAMA 244:2621-2624 (Pubitemid 11192750)
113. Mijovic CH, Fletcher JA, Bradwell AR, Barnett AH (1987) Low C4 levels in type 1 (insulin-dependent) diabetes. Diabetologia 30:824
114. Vergani D, Johnston C, B-Abdullah N, Barnett AH (1983) Low serum C4 concentrations: an inherited predisposition to insulin dependent diabetes? Br Med J (Clin Res Ed) 286:926-928 (Pubitemid 13152757)
115. Jenhani F, Bardi R, Gorgi Y, Ayed K, Jeddi M (1992) C4 polymorphism in multiplex families with insulin dependent diabetes in the Tunisian population: standard C4 typing methods and RFLP analysis. J Autoimmun 5:149-160
116. Hernández-Mijares A, Jarabo-Bueno MM, López-Ruiz A, Solá-Izquierdo E, Morillas-Ariño C, Martínez-Triguero ML (2007) Levels of C3 in patients with severe, morbid and extreme obesity: its relationship to insulin resistance and different cardiovascular risk factors. Int J Obes (Lond) 31:927-932 (Pubitemid 46842689)
117. Karlsson E, Shaat N, Groop L (2008) Can complement factors 5 and 8 and transthyretin be used as biomarkers for MODY 1 (HNF4A-MODY) and MODY 3 (HNF1A-MODY)? Diabet Med 25:788-791
118. Davin JC, Bouts AH, Krediet RT, van der Weel M, Weening RS, Groothoff J, Out TA (1997) IgG glycation and function during continuous ambulatory peritoneal dialysis. Nephrol Dial Transplant 12:310-314 (Pubitemid 27090985)
119. Hostetter MK (1990) Handicaps to host defense. Effects of hyperglycemia on C3 and Candida albicans. Diabetes 39:271-275 (Pubitemid 20076208)
120. Warren S (1930) Pathology of diabetes mellitus. Lea & Febiger, Philadelphia
121. Rayfield EJ, Ault MJ, Keusch GT, Brothers MJ, Nechemias C, Smith H (1982) Infection and diabetes: the case for glucose control. Am J Med 72:439-450 (Pubitemid 12188680)
122. King JT Jr, Goulet JL, Perkal MF, Rosenthal RA (2011) Glycemic control and infections in patients with diabetes undergoing noncardiac surgery. Ann Surg 253:158-165
123. Davis TME, Weerarathne T, Foong Y, Mason C, Davis WA (2005) Community-acquired infections in type 2 diabetic patients and their nondiabetic partners. The Fremantle Diabetes Study. J Diabetes Complications 19:259-263 (Pubitemid 41169822)
124. Stegenga ME, van der Crabben SN, Blümer RME, Levi M, Meijers JCM, Serlie MJ, Tanck MWT, Sauerwein HP, van der Poll T (2008) Hyperglycemia enhances coagulation and reduces neutrophil degranulation, whereas hyperinsulinemia inhibits fibrinolysis during human endotoxemia. Blood 112:82-89
125. Stegenga ME, van der Crabben SN, Dessing MC, Pater JM, van den Pangaart PS, de Vos AF, Tanck MW, Roos D, Sauerwein HP, van der Poll T (2008) Effect of acute hyperglycaemia and/or hyperinsulinaemia on proinflammatory gene expression, cytokine production and neutrophil function in humans. Diabet Med 25:157-164 (Pubitemid 351293406)
126. Dandona P, Aljada A, Mohanty P, Ghanim H, Hamouda W, Assian E, Ahmad S (2001) Insulin inhibits intranuclear nuclear factor κB and stimulates IκB in mononuclear cells in obese subjects: evidence for an anti-inflammatory effect? J Clin Endocrinol Metab 86:3257-3265 (Pubitemid 32674120)
127. Hansen TK, Thiel S, Wouters PJ, Christiansen JS, Van den Berghe G (2003) Intensive insulin therapy exerts antiinflammatory effects in critically ill patients and counteracts the adverse effect of low mannose-binding lectin levels. J Clin Endocrinol Metab 88:1082-1088 (Pubitemid 36337759)
128. Esmann V (1972) The diabetic leukocyte. Enzyme 13:32-55
129. Leroux JP, Marchand JC, Hong Tuan Ha R, Cartier P (1975) The influence of insulin on glucose permeability and metabolism of human granulocytes. Eur J Biochem 58:367-373
130. Sbarra AJ, Karnovsky ML (1959) The biochemical basis of phagocytosis. I. Metabolic changes during the ingestion of particles by polymorphonuclear leukocytes. J Biol Chem 234:1355-1362
131. Maianski NA, Geissler J, Srinivasula SM, Alnemri ES, Roos D, Kuijpers TW (2004) Functional characterization of mitochondria in neutrophils: a role restricted to apoptosis. Cell Death Differ 11:143-153 (Pubitemid 38159638)
132. van den Berghe G, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz M, Vlasselaers D, Ferdinande P, Lauwers P, Bouillon R (2001) Intensive insulin therapy in the critically ill patients. N Engl J Med 345:1359-1367
133. van den Berghe G, Wilmer A, Hermans G, Meersseman W, Wouters PJ, Milants I, Van Wijngaerden E, Bobbaers H, Bouillon R (2006) Intensive insulin therapy in the medical ICU. N Engl J Med 354:449-461 (Pubitemid 43200296)
134. Griesdale DEG, de Souza RJ, van Dam RM, Heyland DK, Cook DJ, Malhotra A, Dhaliwal R, Henderson WR, Chittock DR, Finfer S, Talmor D (2009) Intensive insulin therapy and mortality among critically ill patients: a meta-analysis including NICE-SUGAR study data. CMAJ 180:821-827
135. UK Prospective Diabetes Study (UKPDS) Group (1998) Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet 352:854-865
136. Dandona P, Aljada A, Ghanim H, Mohanty P, Tripathy C, Hofmeyer D, Chaudhuri A (2004) Increased plasma concentration of macrophage migration inhibitory factor (MIF) and MIF mRNA in mononuclear cells in the obese and the suppressive action of metformin. J Clin Endocrinol Metab 89:5043-5047 (Pubitemid 39391446)
137. Fitzgerald E, Mathieu S, Ball A (2009) Metformin associated lactic acidosis. BMJ 339:b3660
138. Jones GC, Macklin JP, Alexander WD (2003) Contraindications to the use of metformin. BMJ 326:4-5 (Pubitemid 36110706)
139. Deakin AM, Payne AN, Blackwell GJ (1994) Role of potassium channels in the regulation of cytokine release from THP-1 cells. Inflamm Res 41:C188-C190 (Pubitemid 24257890)
140. Lamkanfi M, Mueller JL, Vitari AC, Misaghi S, Fedorova A, Deshayes K, Lee WP, Hoffman HM, Dixit VM (2009) Glyburide inhibits the Cryopyrin/Nalp3 inflammasome. J Cell Biol 187:61-70
141. + channels in arterial smooth muscle. Science 245:177-180 (Pubitemid 19193933)
142. Landry DW, Oliver JA (1992) The ATP-sensitive K+ channel mediates hypotension in endotoxemia and hypoxic lactic acidosis in dog. J Clin Invest 89:2071-2074
143. Warrillow S, Egi M, Bellomo R (2006) Randomized, double-blind, placebo-controlled crossover pilot study of a potassium channel blocker in patients with septic shock. Crit Care Med 34:980-985
144. Morelli A, Lange M, Ertmer C, Broeking K, Van Aken H, Orecchioni A, Rocco M, Bachetoni A, Traber DL, Landoni G, Pietropaoli P, Westphal M (2007) Glibenclamide dose response in patients with septic shock: effects on norepinephrine requirements, cardiopulmonary performance, and global oxygen transport. Shock 28:530-535 (Pubitemid 350287437)
145. Mohanty P, Aljada A, Ghanim H, Hofmeyer D, Tripathy D, Syed T, Al-Haddad W, Dhindsa S, Dandona P (2004) Evidence for a potent antiinflammatory effect of rosiglitazone. J Clin Endocrinol Metab 89:2728-2735
146. Ghanim H, Garg R, Aljada A, Mohanty P, Kumbkarni Y, Assian E, Hamouda W, Dandona P (2001) Suppression of nuclear factor-kappaB and stimulation of inhibitor kappaB by troglitazone: evidence for an anti-inflammatory effect and a potential antiatherosclerotic effect in the obese. J Clin Endocrinol Metab 86:1306-1312 (Pubitemid 32323021)
147. Lee S, Kim W, Kang KP, Moon S-O, Sung MJ, Kim DH, Kim HJ, Park SK (2005) Agonist of peroxisome proliferator-activated receptor-gamma, rosiglitazone, reduces renal injury and dysfunction in a murine sepsis model. Nephrol Dial Transplant 20:1057-1065 (Pubitemid 40862093)
148. Wu W-T, Lee C-C, Lee C-J, Subeq Y-M, Lee R-P, Hsu B-G (2011) Rosiglitazone ameliorates endotoxin-induced organ damage in conscious rats. Biol Res Nurs 13:38-43
149. Stegenga ME, Florquin S, de Vos AF, van der Poll T (2009) The thiazolidinedione ciglitazone reduces bacterial outgrowth and early inflammation during Streptococcus pneumoniae pneumonia in mice. Crit Care Med 37:614-618
150. Zingarelli B, Cook JA (2005) Peroxisome proliferator-activated receptor-gamma is a new therapeutic target in sepsis and inflammation. Shock 23:393-399 (Pubitemid 40571660)